Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological treatment for insomnia in patients with major depressive disorder
Elisa Brietzke, Gustavo Vázquez, Melody J.Y. Kang, et al.
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 11, pp. 1341-1349
Open Access | Times Cited: 20

Showing 20 citing articles:

Tolerance-inducing effect and properties of innate immune stimulation on chronic stress-induced behavioral abnormalities in mice
Yue Gu, Ting Ye, Pingping Tan, et al.
Brain Behavior and Immunity (2020) Vol. 91, pp. 451-471
Closed Access | Times Cited: 45
Prevalence and clinical correlates of benzodiazepine use in the patients with major depressive disorder
Chongze Wang, Xiaoxiao Wang, Jinde Wang, et al.
Journal of Affective Disorders (2024) Vol. 363, pp. 619-625
Open Access | Times Cited: 4
Sex Hormones and Serotonin 4 Receptor Brain Binding in Men with and without Major Depressive Disorder
Malene Ravn Aarestrup, Kristian H. R. Jensen, Søren Vinther Larsen, et al.
Neuroscience Applied (2025), pp. 105517-105517
Open Access
Efficacy of inflammation-based stratification for add-on celecoxib or minocycline in Major Depressive Disorder: Protocol of the INSTA-MD double-blind placebo-controlled randomised clinical trial
Céline Wessa, J. Janssens, Violette Coppens, et al.
Brain Behavior & Immunity - Health (2024) Vol. 41, pp. 100871-100871
Open Access | Times Cited: 2
<p>Feasibility of Patient-Controlled Sleep with Dexmedetomidine in Treating Chronic Intractable Insomnia</p>
Jian‐Xiong An, John P. Williams, Qi-Wu Fang, et al.
Nature and Science of Sleep (2020) Vol. Volume 12, pp. 1033-1042
Open Access | Times Cited: 17
Intranasal Monophosphoryl Lipid a Administration Ameliorates depression-like Behavior in Chronically Stressed Mice Through Stimulation of Microglia
Meng Zheng, Tao Zhu, Bingran Chen, et al.
Neurochemical Research (2023) Vol. 48, Iss. 10, pp. 3160-3176
Closed Access | Times Cited: 6
Effect of insomnia in the major depressive disorder
Guohong Xu, Xiaoling Li, Caixia Xu, et al.
BMC Neurology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Microglial stimulation triggered by intranasal lipopolysaccharide administration produces antidepressant-like effect through ERK1/2-mediated BDNF synthesis in the hippocampus
Mingxie Ni, Meng Zheng, Bingran Chen, et al.
Neuropharmacology (2023) Vol. 240, pp. 109693-109693
Closed Access | Times Cited: 5
Functional electrical stimulation of the facial muscles to improve symptoms in individuals with major depressive disorder: pilot feasibility study
Naaz Kapadia, Vera Zivanovic, Bastien Moineau, et al.
BioMedical Engineering OnLine (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 14
Predicting Antidepressant Citalopram Treatment Response via Changes in Brain Functional Connectivity After Acute Intravenous Challenge
Manfred Klöbl, Gregor Gryglewski, Lucas Rischka, et al.
Frontiers in Computational Neuroscience (2020) Vol. 14
Open Access | Times Cited: 13
Psychoneuroendocrine profiles of unmedicated men with major depressive disorder and associations to treatment effects and sexual side-effects
Kristian H. R. Jensen, Malene Ravn Aarestrup, Søren Vinther Larsen, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104050-104050
Open Access | Times Cited: 1
Economic and clinical burden of major depressive disorder with insomnia symptoms in commercially and medicaid-insured adults in the United States: A retrospective matched cohort study
Hrishikesh Kale, Maryia Zhdanava, Dominic Pilon, et al.
Journal of Affective Disorders (2024)
Open Access | Times Cited: 1
Intranasal administration of lipopolysaccharide reverses chronic stress-induced depression-like behavior in mice by microglial stimulation
Chao Huang, Ting Ye, Bingran Chen, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110347-110347
Closed Access | Times Cited: 3
Monophosphoryl Lipid A Tolerance Against Chronic Stress-Induced Depression-Like Behaviors in Mice
Li Fu, Xu Lu, Yao‐Ying Ma, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 25, Iss. 5, pp. 399-411
Open Access | Times Cited: 5
Swiss GPs’ preferences for antidepressant treatment in mild depression: vignette-based quantitative analysis
Michael P. Hengartner, Stefan Neuner‐Jehle, Oliver Senn
BMC Family Practice (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Research Progress on the Effect of Dexmedetomidine on Postoperative Sleep Quality
港 罗
Advances in Clinical Medicine (2024) Vol. 14, Iss. 04, pp. 1541-1546
Closed Access
Managing insomnia in Elderly patients: Evidence-based treatment approaches
Rupam Singh, Pallavi Pallavi, Jagdish Kumar Arun, et al.
Multidisciplinary Reviews (2024) Vol. 6, pp. 2023ss049-2023ss049
Open Access
Microglia stimulation produces antidepressant-like effects in a mouse depression model induced by adolescent chronic unpredictable stress
Hanxiao Wang, Jie Peng, Hao‐Jie Zhu, et al.
Physiology & Behavior (2024) Vol. 291, pp. 114782-114782
Closed Access
Development of new rapid-action treatments in mood disorders
Elisa Macedo Brietzke, Rodrigo B. Mansur, Fabiano A. Gomes, et al.
Elsevier eBooks (2020), pp. 139-146
Closed Access
Poor sleep in medicated patients with remitted depressive disorder: A naturalistic study
IHui Lee, Tsung‐Hua Lu, Po See Chen, et al.
Taiwanese Journal of Psychiatry (2020) Vol. 34, Iss. 1, pp. 42-42
Open Access
Page 1

Scroll to top